Lasa Supergenerics Ltd
NSE:LASA
Lasa Supergenerics Ltd
NSE:LASA
Price:
6.87
INR
4.89%
Market Closed
Market Cap:
₹344.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lasa Supergenerics Ltd
NSE:LASA
|
IN |
|
S
|
Swing Media Technology Group Ltd
SGX:BEV
|
HK |
|
N
|
Net A Go Technology Co Ltd
HKEX:1483
|
HK |
|
Perella Weinberg Partners
NASDAQ:PWP
|
US |
|
L
|
Lena Lighting SA
WSE:LEN
|
PL |
|
Stockwik Forvaltning AB
STO:STWK
|
SE |
|
Q
|
Qumu Corp
F:RMG
|
US |
|
N
|
Nordhealth AS
OSE:NORDH
|
NO |
|
Tarsons Products Ltd
NSE:TARSONS
|
IN |
|
Lamprell Plc
LSE:LAM
|
AE |
Multiples-Based Value
The Multiples-Based Value of one
LASA
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 6.87 INR,
Lasa Supergenerics Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LASA Multiples-Based Value
LOCKED
Multiples Across Competitors
LASA Competitors Multiples
Lasa Supergenerics Ltd Competitors
Lasa Supergenerics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Lasa Supergenerics Ltd
NSE:LASA
|
344.2m INR | 0.5 | -0.8 | -29.7 | -3.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.9 | 44 | 29.6 | 31.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
